Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1,960

Quantum computing isn’t yet far enough along that it could have helped curb the spread of this coronavirus outbreak. But this emerging field of computing will almost certainly help scientists and researchers confront future crises.

“Can we compress the rate at which we discover, for example, a treatment or an approach to this?” asks Dario Gil, the director of IBM Research. “The goal is to do everything that we are doing today in terms of discovery of materials, chemistry, things like that, (in) factors of 10 times better, 100 times better,”

And that, he says, “could be game-changing.”

Read more | >

A population of stem cells with the ability to generate new bone has been newly discovered by a group of researchers at the UConn School of Dental Medicine.

In the journal Stem Cells, lead investigator Dr. Ivo Kalajzic, professor of reconstructive sciences, postdoctoral fellows Dr. Sierra Root and Dr. Natalie Wee, and collaborators at Harvard, Maine Medical Research Center, and the University of Auckland present a new population of cells that reside along the vascular channels that stretch across the bone and connect the inner and outer parts of the bone.

“This is a new discovery of perivascular cells residing within the bone itself that can generate new bone forming cells,” said Kalajzic. “These cells likely regulate bone formation or participate in bone mass maintenance and repair.”

Read more | >

Essentially the microchip that heals article turns the normal process of healing into an accelerated way but eventually crispr could be used to make super fast healing and regeneration.

Normal wound healing is a dynamic and complex multiple phase process involving coordinated interactions between growth factors, cytokines, chemokines, and various cells. Any failure in these phases may lead wounds to become chronic and have abnormal scar formation. Chronic wounds affect patients’ quality of life, since they require repetitive treatments and incur considerable medical costs. Thus, much effort has been focused on developing novel therapeutic approaches for wound treatment. Stem-cell-based therapeutic strategies have been proposed to treat these wounds. They have shown considerable potential for improving the rate and quality of wound healing and regenerating the skin. However, there are many challenges for using stem cells in skin regeneration. In this review, we present some sets of the data published on using embryonic stem cells, induced pluripotent stem cells, and adult stem cells in healing wounds. Additionally, we will discuss the different angles whereby these cells can contribute to their unique features and show the current drawbacks.

Read more | >

Wuhan Coronavirus Pandemic Washington State.

More deaths and it looks like they’re going to look at previous deaths at the retirement home that is the epicenter to see if some of those previous deaths were caused by Wuhan Coronavirus.

“Killian went on to say that since February 19, Life Care Center reported 26 deaths. Since that date, 11 additional patients died at the facility. They generally have three to seven deaths a month, Killian said. Life Care Center is still waiting back for reports on post-mortem testing and whether 11 of those patients tested positive for coronavirus.”

SEATTLE — Another death from coronavirus in King County was reported Saturday, bringing the total to 16 in Washington state. So far, at least 103 have tested positive for COVID-19 in the state.

The new death comes just a day after three people died at at EvergreenHealth Hospital, where now 12 deaths have occurred, hospital officials said. One earlier reported death occurred in a patient never hospitalized and the other was a death at Harborview last week that was later found to have been likely caused by COVID-19. In total, there are 27 confirmed cases of coronavirus at EvergreenHealth.

Of the 15 coronavirus deaths reported in King County, 13 are associated with Life Care Center In Kirkland. Eighteen residents have also tested positive for COVID-19, according to Tim Killian, public liaison for Life Care Center.

Continue reading “16 deaths from COVID-19 in Washington as officials scramble to contain” | >

In the past few decades, researchers discovered that the rate at which we age is strongly influenced by biochemical processes that, at least in animal models, can be controlled in the laboratory. Telomere shortening is one of these processes; another is the ability of cells to detect nutrients mediated by the mTOR protein. Researchers have been able to prolong life in many species by modifying either one of them. But what if they manipulate both?

A team from the Spanish National Cancer Research Centre (CNIO) has studied it for the first time, with unexpected results. Blocking nutrient sensing by treatment with rapamycin, an mTOR inhibitor, delays the aging of healthy , but curiously, it worsens diseases and premature aging that occur in mice with short telomeres. This finding has important implications for the treatment of diseases associated with short telomeres, but also for that are also associated with short telomeres. The study, done by the Telomeres and Telomerase Group headed by Maria Blasco at the CNIO, is published in Nature Communications with Iole Ferrara-Romeo as the first author.

Telomeres, regions of repetitive nucleotide sequences at the end of chromosomes, preserve the genetic information of the cells. They shorten with age until they can no longer fulfill their function: The cells stop dividing and the tissues age since they are no longer able to regenerate.

Read more | >

Amid a coronavirus outbreak in the United States, the US Centers for Disease Control and Prevention is encouraging older people and people with severe chronic medical conditions to “stay at home as much as possible.”

This advice is on a CDC website that was posted Thursday, according to a CDC spokeswoman.

Early data suggests older people are twice as likely to have serious illness from the novel coronavirus, according to the CDC.

Read more | >

Avigan was developed as a flu medicine and also has been used for Ebola virus disease (EVD) treatment. EVD, which causes fatal hemorrhagic fever, resulted in more than 11,300 deaths in the West Africa region between 2014 and 2016. There is currently another outbreak in the Democratic Republic of Congo that has seen more than 2,000 fatalities to date.

HONG KONG – Fujifilm Holdings Corp. stock (TYO:4901) jumped 8.8% to ¥5,890 (US$53.48) on Feb. 25, as Japan considers using Avigan (favipiravir), an anti-influenza medication developed by the company’s Toyama Chemical Co. Ltd., to treat COVID-19. The share price ended the day at ¥5,567, for a gain of 2.83%.

The medication attracted market attention when Minister of Health, Labor and Welfare Katsunobu Kato said on Feb. 22 that the country is planning to test Avigan against COVID-19. “We hear from foreign countries that some drugs among those that have been used against influenza may be useful,” Kato said.

As of Feb. 25, more than 850 cases have been confirmed in Japan.

Read more | >